News from 2019
- Jan (24)
- Feb (27)
- Mar (15)
- Apr (23)
- May (34)
- Jun (28)
- Jul (26)
- Aug (11)
- Sep (19)
- Oct (20)
- Nov (28)
- Dec (14)
- Jan (14)
- Feb (22)
- Mar (21)
- Apr (12)
- May (20)
- Jun (23)
- Jul (20)
- Aug (5)
- Sep (19)
- Oct (19)
- Nov (26)
- Dec (15)
- Jan (4)
- Feb (18)
- Mar (13)
- Apr (15)
- May (19)
- Jun (22)
- Jul (18)
- Aug (9)
- Sep (11)
- Oct (25)
- Nov (19)
- Dec (15)
- Jan (12)
- Feb (6)
- Mar (13)
- Apr (5)
- May (7)
- Jun (15)
- Jul (11)
- Aug (3)
- Sep (5)
- Oct (8)
- Nov (15)
- Dec (13)
How to enjoy the Christmas holidays without putting on weight
Numerous studies have shown that most people put on weight over the Christmas holidays. Huge meals and a lack of physical exercise are two reasons be1
Immunotherapy: an innovative and efficient tool in the battle against haematological tumours
In recent years, one of the strategies developed in the field of haematology is the modification of the patient’s immune system, also known as ‘immun1
A new biological treatment could replace chemotherapy in patients with aggressive breast cancer
Today the results of the phase 2 CORALLEEN clinical trial, promoted by the international academic group SOLTI, have been presented. The study, publis1
Liver fibrosis could be treated with gold nanoparticles
Researchers at IDIBAPS, CIBERehd and ICFO implement gold nanoparticles and plasmonics to treat liver fibrosis in mice.
Objective for 2020: reduce the spread of HIV by 90%
Despite the enormous progress made in the treatment of HIV, the spread of HIV remains uncontrolled around the world. The number of new infections has1
Intermittent fasting: a good strategy for weight loss?
There are indications that intermittent fasting could help with weight loss. Although still in the preliminary stages, studies show that this practic1
Scientists establish the safe dose of statins to use in combination with an antibiotic in the treatment of advanced cirrhosis
A study coordinated by researchers of the Clínic-IDIBAPS and published in The Lancet Gastroenterology & Hepatology establishes the safe dose of simva1
Researchers identify a molecular mechanism involved in neuronal degeneration caused by Huntington’s disease
Researchers from the IDIBAPS and the Institute of Neurosciences of the University of Barcelona (UBNeuro) described a mechanism, the increase of prote1
Continuous glucose monitoring reduces the risk of hypoglycaemia
Studies carried out in the 1990s showed that controlling glucose levels through multiple doses of insulin reduced the risk of complications, but incr1